Elhakim Tarig S, Smolinski-Zhao Sara, Miyasato Dominie, Lee Vladlena, Mansur Arian, Puello Maria, Mercaldo Nathaniel, McKenney Anna Sophia, Kalva Sanjeeva P, Dezube Michael, Daye Dania
Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Department of Radiology, Massachusetts General Hospital, Boston.
JAMA Netw Open. 2025 Sep 2;8(9):e2532100. doi: 10.1001/jamanetworkopen.2025.32100.
Uterine fibroid embolization (UFE) is a minimally invasive alternative to surgery. Understanding utilization patterns and disparities in access is important to ensure that patients can explore all treatment options.
To examine trends in the use of UFE vs hysterectomy and myomectomy for uterine fibroid management, with an emphasis on sociodemographic and institutional disparities.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis used data from the 2016 to 2022 National Inpatient Sample obtained from the Healthcare Cost and Utilization Project, a population-based, multicenter inpatient dataset representing hospitals across the US. Adult patients with a diagnosis of uterine fibroids who underwent hysterectomy, myomectomy, or UFE were identified using International Statistical Classification of Diseases, Tenth Revision, Clinical Modification codes. Analysis was conducted in April 2025.
Patient age, race, ethnicity, insurance, income quartile, rurality, year of procedure, and hospital characteristics.
The primary outcome was undergoing UFE, modeled using multivariable logistic regression, with hysterectomy, myomectomy, or surgery overall as reference groups. The covariate reference categories were age younger than 30 years, White race, private insurance, 76th to 100th income percentile, central metropolitan residence, the year 2016, small hospitals, rural hospitals, and hospitals in the Pacific division. Results were reported as adjusted odds ratios (aORs) with 95% CIs.
The sample encompassed 271 885 encounters, including 199 625 hysterectomies (73.4%), 62 675 myomectomies (23.1%), and 9585 UFEs (3.5%). The median (IQR) patient age was 47 (43-52) years for those undergoing hysterectomy, 45 (40-49) years for those undergoing UFE, and 37 (33-41) years for those undergoing myomectomy. With regard to race and ethnicity, 105 780 patients (38.9%) were African American, 16 175 (5.9%) were Asian or Pacific Islander, 48 810 (18.0%) were Hispanic, 1050 (0.4%) were Native American, 86 425 were White (31.8%), and 13 645 (5.0%) were other races. Increasing age was associated with lower odds of undergoing UFE vs hysterectomy, and higher odds of undergoing UFE vs myomectomy. African American patients were more likely to undergo UFE than hysterectomy (aOR, 1.64; 95% CI, 1.44-1.87), but less likely to undergo UFE than myomectomy (aOR, 0.84; 95% CI, 0.73-0.97). Hispanic patients were less likely to undergo UFE than both surgical procedures (aOR, 0.83; 95% CI, 0.71-0.97). Patients with Medicaid (aOR, 1.58; 95% CI, 1.41-1.77), self-pay (aOR, 1.97; 95% CI, 1.60-2.42), and no-charge (aOR, 1.97; 95% CI, 1.24-3.12) coverage had higher odds of undergoing UFE vs both surgical procedures. Among Medicare patients, UFE was more likely than myomectomy among those aged 30 to 49 years, but less likely among those aged 50 years and older. Those in the lowest income quartile (0-25th percentile) had greater odds of undergoing UFE vs myomectomy (aOR, 1.22; 95% CI, 1.04-1.43). Rural patients were less likely to undergo UFE than hysterectomy (aOR, 0.53; 95% CI, 0.34-0.83), whereas urban hospitals were more likely to perform UFE than both surgical procedures (aOR, 7.13; 95% CI, 3.43-14.80).
In this cross-sectional study, UFE was underutilized with significant disparities across socioeconomic factors. Further efforts are needed to equitably expand access to UFE across the country.
子宫纤维瘤栓塞术(UFE)是一种微创手术,可替代手术。了解其使用模式和获取方面的差异对于确保患者能够探索所有治疗选择很重要。
研究UFE与子宫切除术和肌瘤切除术治疗子宫纤维瘤的使用趋势,重点关注社会人口统计学和机构差异。
设计、设置和参与者:这项横断面分析使用了2016年至2022年全国住院患者样本的数据,该样本来自医疗成本和利用项目,这是一个基于人群的多中心住院数据集,代表了美国各地的医院。使用国际疾病分类第十版临床修订本代码识别诊断为子宫纤维瘤并接受子宫切除术、肌瘤切除术或UFE的成年患者。分析于2025年4月进行。
患者年龄、种族、民族、保险、收入四分位数、农村地区、手术年份和医院特征。
主要结局是接受UFE,使用多变量逻辑回归建模,以子宫切除术、肌瘤切除术或总体手术作为参考组。协变量参考类别为年龄小于30岁、白人种族、私人保险、收入百分位数第76至100位、中心大都市居住、2016年、小型医院、农村医院和太平洋分区的医院。结果以调整后的优势比(aOR)及95%置信区间(CI)报告。
样本包括271885次就诊,其中199625例子宫切除术(73.4%)、62675例肌瘤切除术(23.1%)和9585例UFE(3.5%)。接受子宫切除术的患者中位(四分位间距)年龄为47(43 - 52)岁,接受UFE的患者为45(40 - 49)岁,接受肌瘤切除术的患者为37(33 - 41)岁。在种族和民族方面,105780名患者(38.9%)为非裔美国人,16175名(5.9%)为亚洲或太平洋岛民,48810名(18.0%)为西班牙裔,1050名(0.4%)为美国原住民,86425名(31.8%)为白人,13645名(5.0%)为其他种族。年龄增加与接受UFE相比子宫切除术的几率降低以及接受UFE相比肌瘤切除术的几率增加相关。非裔美国患者接受UFE的可能性高于子宫切除术(aOR,1.64;95%CI,1.44 - 1.87),但低于肌瘤切除术(aOR,0.84;95%CI,0.73 - 0.97)。西班牙裔患者接受UFE的可能性低于两种手术(aOR,0.83;95%CI,0.71 - 0.97)。有医疗补助(aOR,1.58;95%CI,1.41 - 1.77)、自费(aOR,1.97;95%CI,1.60 - 2.42)和免费(aOR,1.97;95%CI,1.24 - 3.12)保险的患者接受UFE的几率高于两种手术。在医疗保险患者中,30至49岁的患者接受UFE的可能性高于肌瘤切除术,但50岁及以上的患者则相反。收入最低四分位数(第0至25百分位)的患者接受UFE相比肌瘤切除术的几率更高(aOR,1.22;95%CI,1.04 - 1.43)。农村患者接受UFE的可能性低于子宫切除术(aOR,0.53;95%CI,0.34 - 0.83),而城市医院进行UFE的可能性高于两种手术(aOR,7.13;95%CI,3.43 - 14.80)。
在这项横断面研究中,UFE的利用率较低,且在社会经济因素方面存在显著差异。需要进一步努力在全国范围内公平地扩大UFE的可及性。